s-nitroso-n-acetylpenicillamine has been researched along with Ovarian Neoplasms in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cai, S; Fan, D; Fan, L; Peng, F; Tao, L; Wang, Q; Zhao, Z; Zheng, N | 1 |
| Fiscus, RR; Fraser, M; Leung, EL; Tsang, BK | 1 |
| Billiar, TR; Chen, JJ; Green, A; Hierholzer, C; Hong, SJ; Kim, YM; Son, K; Tzeng, E | 1 |
| Angioli, R; Averette, H; Braunschweiger, P; Cantuaria, G; Magalhaes, A; Mendez, L; Mirhashemi, R; Penalver, M; Wang, J; Wang, P | 1 |
4 other study(ies) available for s-nitroso-n-acetylpenicillamine and Ovarian Neoplasms
| Article | Year |
|---|---|
Nitric oxide affects cisplatin cytotoxicity oppositely in A2780 and A2780-CDDP cells via the connexin32/gap junction.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cell Line, Tumor; Cell Proliferation; Cisplatin; Connexins; Drug Resistance, Neoplasm; Female; Gap Junction beta-1 Protein; Gap Junctions; Humans; Nitric Oxide; Nitric Oxide Donors; Ovarian Neoplasms; RNA, Small Interfering; S-Nitroso-N-Acetylpenicillamine; Time Factors | 2020 |
Cisplatin alters nitric oxide synthase levels in human ovarian cancer cells: involvement in p53 regulation and cisplatin resistance.
Topics: Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cisplatin; Drug Resistance, Neoplasm; Female; Humans; Nitric Oxide Donors; Nitric Oxide Synthase; Ovarian Neoplasms; RNA, Small Interfering; S-Nitroso-N-Acetylpenicillamine; Tumor Suppressor Protein p53 | 2008 |
Inhibition of protein synthesis by nitric oxide correlates with cytostatic activity: nitric oxide induces phosphorylation of initiation factor eIF-2 alpha.
Topics: Animals; Cell Division; Cells, Cultured; Eukaryotic Initiation Factor-2; Female; Gene Expression Regulation, Enzymologic; Humans; Islets of Langerhans; L Cells; Macrophages, Peritoneal; Mice; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Ovarian Neoplasms; Penicillamine; Phosphorylation; Protein Biosynthesis; Ribosomes; RNA, Messenger; S-Nitroso-N-Acetylpenicillamine; Vaccinia virus; Virus Replication | 1998 |
Antitumor activity of a novel glyco-nitric oxide conjugate in ovarian carcinoma.
Topics: Drug Screening Assays, Antitumor; Female; Humans; Immunohistochemistry; Monosaccharide Transport Proteins; Nitric Oxide; Nitric Oxide Donors; Ovarian Neoplasms; Penicillamine; S-Nitroso-N-Acetylpenicillamine; Tumor Cells, Cultured | 2000 |